The lidERA Breast Cancer study is a phase 3, randomized, open-label trial testing whether the adjuvant therapy giredestrant ...

The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is ...

Endocrine-disrupting chemicals (EDCs) are a class of chemicals that mimic, block or interfere with the production, metabolism or action of hormones in the body. As EDCs are ubiquitous in our ...

The endocrine system plays a crucial role in regulating physiological processes and maintaining homeostasis. While previous ...

The endocrine system is the name for the glands that produce hormones in a person’s body. These glands include the thyroid gland, pituitary gland, and adrenal gland. The endocrine system produces ...

Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...

Endocrine therapy is a way of treating conditions such as cancer using hormones. Also known as hormone therapy, it involves adjusting the levels of certain hormones, such as testosterone, estrogen, ...

An Italian survey finds wide variability in post-kidney transplant endocrine care: Many clinics lack endocrine input; ...

Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

The endocrine system is made up of certain special glands and the hormones produced by those glands in the body. The hormones are important for instructing specific cells to produce particular actions ...